- Fee assured
- Verified this account
- Lower GI
- Upper GI
Professor Bridgewater is a Clinical Researcher at the UCL Cancer Institute. He trained in medicine at Oxford and University College London, and specialised in Medical Oncology at the Middlesex, Mount Vernon and Royal Marsden Hospitals. He holds a PhD in gene therapy from the Institute of Cancer Research.
Areas of interest
Colorectal (bowel) cancer; Gastro-intestinal oncology; carcinoma of unknown primary
Current NHS consultant posts held
Professor Bridgewater leads and coordinates the NCRI hepatobiliary portfolio. He has developed an international collaboration of biliary tract investigators the collaboration with whom is essential for future studies.
Professor Bridgewater leads the National Cancer Research Institute subgroup in hepatobiliary malignancy, and has a laboratory programme at the UCL Cancer Institute investigating carcinoma of unknown primary origin. He serves on a number of committees including those for the NCRI (UGI and colorectal), CTAAC and NICE.
Reference number 3168013
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-14 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-21 days - (5-50)
Insertion of implantable central venous port (portacath) e.g Port-a-Cath under image guidance - (1-5)
Rivers Hospital (1-5)
- Show All (10)...